Operating Lease, Right-of-Use Asset in USD of Moderna, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Moderna, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • Moderna, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $738,000,000, a 5.9% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Moderna, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $738,000,000 -$46,000,000 -5.9% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $750,000,000 -$25,000,000 -3.2% 30 Jun 2025 10-Q 01 Aug 2025 2025 Q2
Q1 2025 $752,000,000 +$55,000,000 +7.9% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $759,000,000 +$46,000,000 +6.5% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $784,000,000 +$19,000,000 +2.5% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $775,000,000 +$645,000,000 +496% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $697,000,000 +$580,000,000 +496% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $713,000,000 +$592,000,000 +489% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $765,000,000 +$652,000,000 +577% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $130,000,000 +$8,000,000 +6.6% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $117,000,000 -$15,000,000 -11% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $121,000,000 -$21,000,000 -15% 31 Dec 2022 10-K 23 Feb 2024 2023 FY
Q3 2022 $113,000,000 -$2,000,000 -1.7% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $122,000,000 +$18,000,000 +17% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $132,000,000 +$43,000,000 +48% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $142,000,000 +$52,000,000 +58% 31 Dec 2021 10-K 24 Feb 2023 2022 FY
Q3 2021 $115,000,000 +$23,316,000 +25% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $104,000,000 +$11,954,000 +13% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $89,000,000 -$11,533,000 -11% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $90,000,000 +$3,586,000 +4.2% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $91,684,000 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $92,046,000 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $100,533,000 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $86,414,000 +$23,080,000 +36% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q4 2018 $63,334,000 01 Jan 2019 10-K 27 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.